AI assistant
Edwards Lifesciences Corp — Director's Dealing 2012
Apr 27, 2012
30042_dirs_2012-04-27_cdf96bfd-45b5-468e-b39d-b7a375087bba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-04-25
Reporting Person: BOWLIN MICHAEL R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-25 | Common Stock | M | 6896.0000 | $11.6000 | Acquired | 78923.0000 | Direct |
| 2012-04-25 | Common Stock | M | 3718.0000 | $21.5100 | Acquired | 82641.0000 | Direct |
| 2012-04-25 | Common Stock | S | 4824.0000 | $80.5100 | Disposed | 77817.0000 | Direct |
| 2012-04-25 | Common Stock | S | 5790.0000 | $82.0200 | Disposed | 72027.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-04-25 | Director Stock Option (Right to Acquire) | $11.6000 | M | 6896.0000 | Disposed | 2012-06-30 | Common Stock (6896.0000) | Direct |
| 2012-04-25 | Director Stock Option (Right to Acquire) | $21.5100 | M | 3718.0000 | Disposed | 2012-06-30 | Common Stock (3718.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2012.
F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
F3: This transaction was executed in multiple trades at prices ranging from $80.00 to $81.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $82.02 to $82.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.